PA-BOOMI
15.4.2024 15:01:27 CEST | Business Wire | Press release
Boomi™, the intelligent integration and automation leader, today announced findings from its Boomi Discovery Report, commissioned by 451 Research.1 The report, based on perspectives from 650 business and IT leaders across a broad range of industries, outlines how enterprises are using Generative AI (GenAI) to integrate systems and automate processes, and how this has helped their business operations as a result.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240415795607/en/
Boomi Discovery Report Reveals More Than Half of Enterprises Invest in GenAI for Integration and Automation (Graphic: Business Wire)
Every business is grappling with growing digital fragmentation – from application sprawl and disconnect between departments, to rising costs and skills shortages. GenAI delivers the promise of more efficient and cost-effective operations and improved customer and employee experiences, but only for businesses that embrace it.
According to the Boomi Discovery Report, organizations are seeing GenAI’s immediate impact on integration. More than half of respondents (55%) said GenAI was very important for integrating data, applications, and processes. Moreover, the global drivers of AI adoption included increased productivity (which 44% of executives cited), increased sales and revenue growth (40%), and improved customer experience (39%).
However, respondents acknowledged the complexity that’s often associated with integration. Many times, integrating data and systems can bring challenges that prompt security and privacy concerns (42%), data quality and availability challenges (42%), and model training, accuracy, and reliability (31%). According to the report, 90% of respondents agree that GenAI has the potential to improve the speed and quality of the development and automation of data, application, and process integrations.
“The ability to seamlessly integrate and automate business processes has long been a top priority for many enterprises,” said Steve Lucas, CEO at Boomi. “As organizations scale and continue to navigate unforeseen business challenges, it will become more difficult to keep track of all the data, technology, and processes necessary to achieve business goals. Generative AI can be a powerful tool for today’s enterprises, streamlining valuable integration and automation practices and freeing IT teams to focus on innovation. Finding ways to leverage GenAI effectively is the next business prerogative. Boomi is not only helping get businesses ready for it, but also leading the GenAI charge in the integration and automation space."
Additional key findings from the report include:
- IT leaders have more trust in GenAI than business leaders: IT CxOs have a higher rate of trust – 82% either “completely” or “somewhat” trust the output of GenAI, versus 63% of business CxOs.
- Accuracy and consistency are major factors driving trust in GenAI: More than half of business leaders (57%) cited accuracy and quality of AI outputs as a factor in their trust of AI. Just under half (48%) cited consistency and reliability as an AI trust factor.
- Enterprise execs see tremendous value in GenAI: Leaders cited improved process accuracy and consistency (38%), cost reduction (38%), innovation and creativity (34%), streamlined operations (31%), optimized resources (28%), and enablement of competitive advantage (27%) as top potential benefits for leveraging GenAI.
- GenAI has widespread value for integrations: All respondents believe that virtually any type of integration would benefit from GenAI-assisted integration platforms.
“Integration and automation are the foundation upon which enterprises build business agility,” said Matt McLarty, CTO at Boomi. “However, integrating and automating systems isn’t always easy. This is why it pays off to have a unified approach for both. With a unified platform, powered by AI technology, enterprises can gain the advantages of comprehensive integration and automation while mitigating unwanted complexity.”
For more information on the 2024 Boomi Discovery Report, click here.
Additional Resources
- Learn more about the Boomi platform
- Follow Boomi on Twitter, LinkedIn, Facebook, and YouTube
About Boomi
Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.
© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
Methodology
The findings presented in this report draw on a survey fielded in North America and Europe in Q4 2023. The survey targeted 650 business and IT decision-makers/influencers in companies ranging in size from under 100 to over 25,000 employees, and $2 million to over $10 billion in annual revenue. The study prioritized respondents with intimate knowledge of automation and integration technology across a broad range of diverse industries asking them about their perception of, and propensity to use, AI technologies of various types, but more specifically about their use of GenAI. The job descriptions of respondents were a mix of executives ranging from Analyst/Manager grade to C-level Executives. This report also draws on contextual knowledge of additional research conducted by S&P Global Market Intelligence.
|
|
1Source: The Impact of AI on Enterprise Integration and Automation, 451 Research, a part of S&P Global Market Intelligence and Boomi, 2024. All Rights Reserved |
|
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240415795607/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
